Ivermectin induces apoptosis of esophageal squamous cell carcinoma via mitochondrial pathway
Abstract Background Esophageal squamous cell carcinoma (ESCC) is the most predominant primary malignant tumor among worldwide, especially in China. To date, the successful treatment remains a mainly clinical challenge, it is imperative to develop successful therapeutic agents. Methods The anti-proli...
Main Authors: | Nana Xu, Mengmeng Lu, Jiaxin Wang, Yujia Li, Xiaotian Yang, Xiajie Wei, Jiaoyang Si, Jingru Han, Xiaojuan Yao, Juanmei Zhang, Junqi Liu, Yanming Li, Hushan Yang, Dengke Bao |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2021-12-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-021-09021-x |
Similar Items
-
Ivermectin contributes to attenuating the severity of acute lung injury in mice
by: Yuanqiao Ma, et al.
Published: (2022-11-01) -
Exosomal FMR1-AS1 facilitates maintaining cancer stem-like cell dynamic equilibrium via TLR7/NFκB/c-Myc signaling in female esophageal carcinoma
by: Wei Li, et al.
Published: (2019-02-01) -
Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway
by: Xiaozhong Liao, et al.
Published: (2020-09-01) -
RETRACTED: Corrigendum: Combination of Tanshinone IIA and Cisplatin Inhibits Esophageal Cancer by Downregulating NF-κB/COX-2/VEGF Pathway
by: Xiaozhong Liao, et al.
Published: (2021-04-01) -
Ivermectin drug induced liver injury
by: Mark Sonderup, et al.
Published: (2023-06-01)